HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jie Peng Selected Research

Paclitaxel (Taxol)

12/2021miR-378d suppresses malignant phenotype of ESCC cells through AKT signaling.
1/2016Development of a validated LC-APCI-MS/MS method to study the plasma and tumor distribution of CHO-PTX intravenous lipid emulsion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jie Peng Research Topics

Disease

46Neoplasms (Cancer)
01/2022 - 12/2006
36Chronic Hepatitis B
12/2022 - 09/2003
26Infections
06/2022 - 05/2008
17Inflammation (Inflammations)
08/2022 - 09/2003
12Fibrosis (Cirrhosis)
06/2020 - 09/2003
9Neoplasm Metastasis (Metastasis)
09/2021 - 03/2010
8Insulin Resistance
08/2022 - 07/2011
8Hepatitis B
06/2021 - 09/2003
7Hepatocellular Carcinoma (Hepatoma)
01/2022 - 01/2014
6Pancreatitis
06/2022 - 03/2018
6Retinal Detachment (Retinal Detachments)
01/2022 - 01/2017
6Obesity
11/2021 - 09/2017
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 05/2015
5Carcinogenesis
01/2022 - 03/2010
5Breast Neoplasms (Breast Cancer)
07/2020 - 03/2010
5Graft vs Host Disease (Graft-Versus-Host Disease)
01/2020 - 08/2013
5Liver Cirrhosis (Hepatic Cirrhosis)
05/2018 - 10/2004
5Stomach Neoplasms (Stomach Cancer)
09/2017 - 12/2006
4Retinopathy of Prematurity (Retrolental Fibroplasia)
09/2022 - 01/2017
4Renal Insufficiency (Renal Failure)
04/2022 - 01/2018
4Retinal Perforations
01/2022 - 11/2018
4Glaucoma
01/2022 - 01/2006
4Disease Progression
01/2021 - 01/2017
4Metabolic Syndrome (Dysmetabolic Syndrome X)
05/2018 - 02/2015
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2016 - 01/2013
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 09/2019
3Sepsis (Septicemia)
09/2021 - 01/2021
3Lung Neoplasms (Lung Cancer)
09/2021 - 01/2013
3Abdominal Obesity
01/2021 - 02/2015
3Body Weight (Weight, Body)
01/2021 - 10/2018
3Ischemia
11/2020 - 09/2011
3Esophageal Squamous Cell Carcinoma
05/2020 - 06/2019
3Wounds and Injuries (Trauma)
01/2020 - 01/2015
3Hypertension (High Blood Pressure)
10/2018 - 01/2014
3Necrosis
03/2018 - 12/2011
3Atherosclerosis
12/2011 - 01/2011
3Carcinoma (Carcinomatosis)
12/2011 - 01/2009
2Mitochondrial Diseases (Mitochondrial Disease)
08/2022 - 09/2021
2Acquired Immunodeficiency Syndrome (AIDS)
06/2022 - 10/2021
2Thrombosis (Thrombus)
04/2022 - 01/2021
2Incontinentia Pigmenti (Bloch Sulzberger Syndrome)
03/2022 - 01/2018
2Cataract (Cataracts)
02/2022 - 01/2016
2Virus Diseases (Viral Diseases)
01/2022 - 01/2019
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 11/2017

Drug/Important Bio-Agent (IBA)

27Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2006
12Pharmaceutical PreparationsIBA
04/2022 - 12/2008
12Hepatitis B e AntigensIBA
01/2021 - 09/2003
11Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2013
11DNA (Deoxyribonucleic Acid)IBA
06/2021 - 09/2003
10RNA (Ribonucleic Acid)IBA
12/2022 - 03/2010
10LipidsIBA
11/2021 - 01/2011
10Antiviral Agents (Antivirals)IBA
06/2021 - 01/2009
9Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2022 - 06/2008
7Messenger RNA (mRNA)IBA
01/2022 - 01/2006
7InterferonsIBA
06/2021 - 06/2005
7Small Interfering RNA (siRNA)IBA
04/2018 - 12/2011
6MicroRNAs (MicroRNA)IBA
06/2019 - 11/2016
5Retinaldehyde (Retinal)IBA
09/2022 - 01/2016
5Ranibizumab (Lucentis)FDA Link
09/2022 - 01/2017
5AntigensIBA
01/2022 - 01/2020
5VaccinesIBA
01/2022 - 01/2020
5Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 10/2018
5Sirtuin 1IBA
09/2021 - 09/2017
5TelbivudineFDA Link
01/2020 - 06/2012
5entecavirFDA Link
06/2017 - 06/2011
4AntioxidantsIBA
08/2022 - 01/2011
4Carbapenems (Carbapenem Antibiotics)IBA
06/2022 - 10/2018
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 07/2011
4adefovirIBA
01/2020 - 01/2009
4AlbuminsIBA
11/2019 - 09/2011
4Alanine Transaminase (SGPT)IBA
01/2019 - 01/2012
4Celecoxib (Celebrex)FDA Link
09/2017 - 06/2004
4BilirubinIBA
07/2012 - 10/2004
3ProcalcitoninIBA
06/2022 - 01/2021
3CytokinesIBA
03/2022 - 03/2018
3Interleukin-10 (Interleukin 10)IBA
11/2021 - 06/2005
3Long Noncoding RNAIBA
07/2021 - 04/2018
3LigandsIBA
01/2021 - 01/2020
3Telomerase (Telomerase Reverse Transcriptase)IBA
02/2020 - 06/2016
3AntibodiesIBA
01/2019 - 01/2009
3Insulin (Novolin)FDA Link
12/2018 - 07/2011
3CholesterolIBA
12/2018 - 01/2016
3Glucose (Dextrose)FDA LinkGeneric
01/2018 - 01/2016
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2016 - 12/2011
3calcium phosphateIBA
06/2016 - 12/2006
3glutathione S-transferase T1IBA
09/2015 - 01/2013
2nasIBA
12/2022 - 01/2021
2Immune Checkpoint InhibitorsIBA
01/2022 - 01/2020
2Capsules (Microcapsules)IBA
01/2022 - 11/2018
2Uric Acid (Urate)IBA
01/2022 - 02/2017
2Triglycerides (Triacylglycerol)IBA
01/2022 - 12/2018
2Paclitaxel (Taxol)FDA LinkGeneric
12/2021 - 01/2016

Therapy/Procedure

43Therapeutics
12/2022 - 10/2004
6Hematopoietic Stem Cell Transplantation
12/2021 - 08/2013
5Transplantation
01/2022 - 08/2013
4Vitrectomy
01/2022 - 01/2017
4Aftercare (After-Treatment)
01/2022 - 02/2017
3Lasers (Laser)
01/2022 - 01/2017
3Intravitreal Injections
01/2018 - 01/2012
2Length of Stay
03/2022 - 01/2021